The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUNG.L Regulatory News (UNG)

  • There is currently no data for UNG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) Universe Group plc

2 Dec 2021 11:30

RNS Number : 3821U
Universe Group PLC
02 December 2021
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Universe Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Universe Group plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

02-12-2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

N/A

N/A

N/A

N/A

(2) Cash-settled derivatives:

 

N/A

N/A

N/A

N/A

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

N/A

N/A

N/A

N/A

 

TOTAL:

N/A

N/A

N/A

N/A

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

(1) Interests of directors (together with their close relatives and related trusts) of Universe Group plc in the ordinary shares of £0.01 each

 

Director

Number of ordinary shares

% of issued ordinary shares (2 d.p.)

Andrew Blazye

20,342,785

7.79%

Neil Radley

1,999,790

0.77%

Malcolm Coster

9,215,754*

3.53%

Ivan Brooks

520,736**

0.20%

Adrian Wilding

200,000

0.08%

 

Director

Number of options

Date of award

Plan

Exercise price

Date from which exercisable

Expiry

Neil Radley

12,700,000

20 July 2021

Unapproved Plan

5.4p

20 July 2024

20 July 2026

Malcolm Coster

100,000

28 October 2014

Unapproved Plan

5.5p

28 October 2017

28 October 2024

Adrian Wilding

5,000,000

20 July 2021

Unapproved Plan

5.4p

20 July 2024

20 July 2026

 

*Includes 6,371,643 shares held in the name of Teresa Coster, who is Malcolm Coster's daughter in law.

 

**Includes 78,236 shares held in the name of Thomas Brooks and 42,500 shares held in the name of Alexander Brooks, who are Ivan Brooks' sons.

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

2 December 2021

Contact name:

Adrian Wilding

Telephone number:

+44 2380 689 510

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEFLFLLFSLFIIL
Date   Source Headline
28th Oct 20093:17 pmRNSProposed renewal and extension of contract
27th Oct 20098:05 amRNSEPT Disclosure
19th Oct 200912:51 pmRNSRule 8.3- Universe Group Plc
16th Oct 200911:39 amRNSEPT Disclosure
14th Oct 200911:19 amRNSEPT Disclosure
7th Oct 20097:49 amRNSEPT Disclosure
6th Oct 20097:00 amRNSUpdate on approach/Contract win
28th Sep 20093:28 pmRNSRule 8.3- (Universe Group plc)
28th Sep 20098:59 amRNSEPT Disclosure
28th Sep 20097:00 amRNSRule 8.1- (Universe Group plc)
25th Sep 20091:49 pmRNSEPT Disclosure
24th Sep 20097:00 amRNSFurther re shareholder enquiries
22nd Sep 20096:00 pmRNSHolding(s) in Company
22nd Sep 20099:01 amRNSEPT Disclosure
21st Sep 20098:37 amRNSEPT Disclosure
17th Sep 20092:18 pmRNSFurther re Holdings in Company
17th Sep 200910:11 amRNSEPT Disclosure
16th Sep 200911:03 amRNSEPT Disclosure
16th Sep 20097:00 amRNSRule 2.10 Announcement
15th Sep 20093:04 pmRNSShare price movement
11th Sep 200912:36 pmRNSHolding(s) in Company
11th Sep 200912:30 pmRNSHolding(s) in Company
12th Aug 20097:00 amRNSHalf Yearly Report
14th Jul 200912:25 pmRNSHolding(s) in Company
14th Jul 200912:04 pmRNSHolding(s) in Company
3rd Jul 20097:00 amRNSTrading Update
11th Jun 200912:05 pmRNSResult of AGM
21st May 20094:05 pmRNSPublication of Report & Accounts
29th Apr 20097:00 amRNSFinal Results
2nd Mar 20097:00 amRNSLaunch of new product
8th Jan 20097:00 amRNSDirector/PDMR Shareholding
23rd Dec 20085:25 pmRNSDirectorate Change
5th Dec 20087:00 amRNSTrading Statement
5th Nov 200811:51 amRNSDirector/PDMR Shareholding
31st Oct 200811:57 amRNSStrategic Partnership
18th Aug 20087:00 amRNSInterim Results
1st Jul 20086:21 pmRNSHolding(s) in Company
1st Jul 20086:18 pmRNSHolding(s) in Company
13th Jun 20088:57 amRNSAnnual Report and Accounts
11th Jun 20087:00 amRNSChange of Adviser
30th May 200811:28 amRNSResult of AGM
15th Apr 20087:01 amRNSFinal Results
2nd Apr 200810:41 amRNSNotice of Results
13th Feb 20087:00 amRNSDirector/PDMR Shareholding
12th Feb 20087:00 amRNSPre Close Statement
27th Nov 200712:28 pmRNSTrading Update
4th Oct 20078:23 amRNSDirectorate Change
28th Aug 200712:23 pmRNSDirector/PDMR Shareholding
17th Aug 20073:43 pmRNSDirector/PDMR Shareholding
15th Aug 20077:01 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.